'It's not like you just had a heart attack': Decision-making about active surveillance by men with localized prostate cancer

Psycho-Oncology

Volumn 23, Issue 4, 2014, Pages 467-472

  Volk, Robert J ^a   McFall, Stephanie L ^b   Cantor, Scott B ^a   Byrd, Theresa L ^c   Le, Yen Chi L ^d   Kuban, Deborah A ^a   Mullen, Patricia Dolan ^d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF ESSEX   (United Kingdom)

^c Texas Tech University Health Sciences Center El Paso   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

cancer; decision making; oncology; prostate neoplasms; qualitative research

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACTIVE SURVEILLANCE; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CLINICAL ARTICLE; CONSULTATION; DISEASE SURVEILLANCE; DOCTOR PATIENT RELATION; EDUCATIONAL STATUS; HUMAN; INTERVIEW; MALE; MEDICAL RECORD REVIEW; PATIENT DECISION MAKING; PATIENT MONITORING; PROSTATE TUMOR; THEMATIC ANALYSIS; ATTITUDE TO HEALTH; DECISION MAKING; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; PSYCHOLOGY; QUALITATIVE RESEARCH; RADIOTHERAPY; WATCHFUL WAITING;

AGED; ATTITUDE TO HEALTH; CHOICE BEHAVIOR; DECISION MAKING; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITATIVE RESEARCH; RADIOTHERAPY; WATCHFUL WAITING;

EID: 84897580997     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3444     Document Type: Article

References (21)

1. Carter HB,. Active surveillance for prostate cancer: an underutilized opportunity for reducing harm. J Natl Cancer Inst Monogr 2012; 45: 175-183.
2. Dahabreh IJ, Chung M, Balk EM, et al,. Active surveillance in men with localized prostate cancer: a systematic review. Ann Intern Med 2012; 156: 582-590.
3. Ganz PA, Barry JM, Burke W, et al,. National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. Ann Intern Med 2012; 156: 591-595.
4. Hall IJ, Richardson LC,. Commentary on the State-of-the-Science Conference on the role of active surveillance in the management of men with localized prostate cancer. J Natl Cancer Inst Monogr 2012; 45: 135-139.
5. Mohler J, Bahnson RR, Boston B, et al,. NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 2010; 8: 162-200.
6. Thompson I, Thrasher JB, Aus G, et al,. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007; 177: 2106-2131.
7. Cooperberg MR, Broering JM, Carroll PR,. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010; 28: 1117-1123.
8. Harlan LC, Potosky A, Gilliland FD, et al,. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst 2001; 93: 1864-1871.
9. Ip S, Dahabreh IJ, Chung M, et al,. An evidence review of active surveillance in men with localized prostate cancer. Evid Rep Technol Assess (Full Rep) 2011; 204: 1-341.
10. Davison BJ, Oliffe JL, Pickles T, Mroz L,. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol Nurs Forum 2009; 36: 89-96.
11. Chapple A, Ziebland S, Herxheimer A, McPherson A, Shepperd S, Miller R,. Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study. BJU Int 2002; 90: 257-264.
12. Steginga SK, Occhipinti S,. The application of the heuristic-systematic processing model to treatment decision making about prostate cancer. Med Decis Making 2004; 24: 573-583.
13. Penson DF,. Factors influencing patients' acceptance and adherence to active surveillance. J Natl Cancer Inst Monogr 2012; 45: 207-212.
14. Schwartz LM, Woloshin S, Fowler FJ, Jr., Welch HG,. Enthusiasm for cancer screening in the United States. JAMA 2004; 291: 71-78.
15. Davison BJ, Goldenberg SL,. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. BJU Int 2011; 108: 1787-1793.
16. Gorin MA, Soloway CT, Eldefrawy A, Soloway MS,. Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology 2011; 77: 588-591.
17. van den Bergh RC, van Vugt HA, Korfage IJ, et al,. Disease insight and treatment perception of men on active surveillance for early prostate cancer. BJU Int 2010; 105: 322-328.
18. Xu J, Neale AV, Dailey RK, Eggly S, Schwartz KL,. Patient perspective on watchful waiting/active surveillance for localized prostate cancer. J Am Board Fam Med 2012; 25: 763-770.
19. Zeliadt SB, Ramsey SD, Penson DF, et al,. Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer 2006; 106: 1865-1874.
20. Hoffman RM,. Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions. J Natl Cancer Inst Monogr 2012; 45: 197-201.
21. Elwyn G, Frosch D, Volandes AE, Edwards A, Montori VM,. Investing in deliberation: a definition and classification of decision support interventions for people facing difficult health decisions. Med Decis Making 2010; 30: 701-711.